支气管喘点应用疗法的效果:多中心随机对照试验
X U Huanfang1, L I Jiashan1, Yang Li1
1Acupuncture and Moxibustion Hospital, Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
|February 25, 2026
概括
点应用疗法 (PAT) 在患有支气管喘的患者中显著减少了喘恶化. 这种治疗也改善了肺功能,但观察到轻微的副作用.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 诸如支气管喘等慢性呼吸道疾病显著影响患者的生活质量.
- 喘恶化对医疗保健系统和患者来说是一个巨大的负担.
- 持续寻求有效的喘恶化管理策略.
研究的目的:
- 评估点应用疗法 (PAT) 在减少喘恶化中的有效性.
- 评估PAT对肺功能参数和喘患者症状控制的影响.
主要方法:
- 一个多中心,随机,安慰剂对照试验,涉及835名支气管喘患者.
- 患者连续两年在夏季狗日期间接受常规或安慰剂PAT.
- 主要结局:24个月喘恶化与基线的变化;次要结局包括肺功能测试和药物使用.
主要成果:
- 与安慰剂相比,PAT显著降低了喘恶化平均次数 (P < 0.001).
- 在24个月前,PAT改善了FEV1% (P = 0.039) 和12个月和24个月后的FEV1/FVC (P = 0.01).
- 在PEF或ACT得分中没有发现显著差异;轻度,与治疗相关的不良事件在PAT组中更频繁.
结论:
- 在夏季的狗日中进行的点应用疗法有效地减少了喘恶化.
- PAT证明了作为治疗性干预治疗支气管喘的潜力.
- 进一步的研究可能会探索PAT的长期影响和最佳应用方案.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
942
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
942
01:11Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
01:30Asthma-IV: Nursing Management
3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.9K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K